| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,280 | 1,285 | 10:10 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.01. | DMS GROUP: EUR 50.0 MILLION IN ANNUAL REVENUE IN 2025, ORGANIC GROWTH OF +9% | 4.274 | Actusnews Wire | Dynamic growth of +17% in activity in Q4 2025, driven by sustained international development
Confirmed acceleration in growth in the 2nd half of 2025 (+14% vs. +3% in the 1st half of 2025)... ► Artikel lesen | |
| 06.01. | DMS GROUP: HALF-YEAR REPORT ON THE LIQUIDITY CONTRACT ON DECEMBER 31, 2025 | 263 | Actusnews Wire | January 6, 2026 - 5.45 pm - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry... ► Artikel lesen | |
| 04.11.25 | DMS GROUP RECEIVES FDA CLEARANCE FOR ITS !M1 MOBILE RADIOLOGY SYSTEM AS PART OF ITS PARTNERSHIP WITH JPI HEALTHCARE SOLUTIONS IN THE UNITED STATES | 870 | Actusnews Wire | A new strategic milestone in DMS Group's expansion in North America ahead of RSNA 2025
November 4, 2025 - 5:45 pm - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS), a... ► Artikel lesen | |
| 20.10.25 | DMS GROUP: ACCELERATION OF GROWTH IN THE 3RD QUARTER 2025 | 823 | Actusnews Wire | Quarterly revenue of €11.0 million, up +10%
Dynamism in the Radiology business (+15% in Q3)
Confirmation of the objective of accelerating growth in the 2nd half of 2025 in a less dynamic... ► Artikel lesen | |
| 29.09.25 | DMS GROUP: SUSTAINED GROWTH IN HALF-YEAR RESULTS FOR 2025 | 997 | Actusnews Wire | New half-year of business growth (+3%) in the 1st half of 2025, in a demanding international environment
Strong EBITDA growth of +82% - EBITDA margin of 7.2% (vs. 4.1%)
+€1.2 million improvement... ► Artikel lesen | |
| DIAGNOSTIC MEDICAL SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 18.08.25 | DMS Group: An International Alliance For European Technological Sovereignty In Medical Imaging - Capital Increase Of A Total Amount Of Eur 6.9 Million Reserved For Innolux, Innocare, Bpifrance And NextStage AM | 757 | Actusnews Wire | A major international industrial alliance, supported by major institutional investors.
DMS Group, a fast-growing European industrial player, is joining forces with two listed Asian technology... ► Artikel lesen | |
| 21.07.25 | DMS GROUP: FURTHER INCREASE IN REVENUE +3% IN H1 2025 | 1.256 | Actusnews Wire | Further increase in a tense market environment and an unfavorable base effect
A 2nd half of 2025 expected to see sustained growth, driven by the implementation of the Ukraine contract and the... ► Artikel lesen | |
| 17.06.25 | STRENGTHENING OF DMS GROUP'S GOVERNANCE STRUCTURE: APPOINTMENT OF JULIEN DELPECH AS AN INDEPENDENT DIRECTOR | 483 | Actusnews Wire | June 17, 2025 - 8:00 am - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS and FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for digital... ► Artikel lesen | |
| 12.06.25 | DMS GROUP: INITIATION OF COVERAGE OF THE STOCK BY ODDO BHF | 540 | Actusnews Wire | June 12, 2025 - 6:00 pm - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS and FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for Digital... ► Artikel lesen | |
| 12.05.25 | DMS GROUP: FDA CLEARANCE FOR THE !M1 SYSTEM AND THE IMMEDIATE COMMERCIALIZATION IN THE UNITED STATES WITH MEDLINK IMAGING | 575 | Actusnews Wire | May 12, 2025 - 8:00 AM - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS et FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for Digital... ► Artikel lesen | |
| 07.05.25 | DMS GROUP: IMPLEMENTATION OF A LIQUIDITY CONTRACT WITH NATIXIS ODDO BHF | 527 | Actusnews Wire | May 7, 2025 - 8:00 AM - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS et FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for Digital Radiology... ► Artikel lesen | |
| 22.04.25 | 2025 FIRST-QUARTER REVENUE: DMS GROUP RECORDS DOUBLE-DIGIT GROWTH | 719 | Actusnews Wire | A growth dynamic that will accelerate by the end of the first half of the year, driven by the start of mobile M1 deliveries in Ukraine
€10.9 M
Turnover
10%
Increase in turnover vs. first... ► Artikel lesen | |
| 14.04.25 | DMS GROUP: DMS Group: ANNUAL RESULTS 2024 - SUSTAINED GROWTH SIGNIFICANT IMPROVEMENT OF OPERATIONAL PROFITABILITY - CONFIRMATION OF THE IMAGING 2027 PLAN | 765 | Actusnews Wire | 2024 revenue with continuous growth: €46.1 million, up 9%
Significant improvement in EBITDA: +57%
Significant reduction in operational costs and overhead costs from the 2nd half of the year
Confirmation... ► Artikel lesen | |
| 07.03.25 | DMS GROUP: DMS Group Selected by Ukrainian Authorities for the Delivery of 120 Emergency Mobile Radiology Units in a Contract Worth EUR 11M | 628 | Actusnews Wire | March 7, 2025 - 10:00 AM - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS and FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for Digital... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CROSS COUNTRY HEALTHCARE | 7,450 | -0,67 % | CROSS COUNTRY HEALTHCARE INC - 8-K, Current Report | ||
| LNA SANTE | 26,000 | -1,14 % | LNA SANTE: 2025 annual sales | ||
| GENEDX | 74,20 | -6,98 % | These Analysts Slash Their Forecasts On GeneDx After Q4 Results | ||
| PROGYNY | 17,600 | 0,00 % | KeyBanc senkt Kursziel für Progyny-Aktie aufgrund konservativer Schätzungen | ||
| PROCEPT BIOROBOTICS | 25,920 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance | SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,570 | +0,46 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,640 | +2,19 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| HEARTFLOW | 24,050 | +4,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| FRESENIUS | 49,190 | -3,13 % | Fresenius: Das ist wichtig | Mit der Aktie von Fresenius ging es im heutigen Handel deutlich bergab. Dies lag vor allem am eher zurückhaltenden Ausblick der Tochter Fresenius Medical Care. Von Fresenius selbst gibt es am Tag vor... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,180 | +0,85 % | DAX fester, Bitcoin tiefer: FMC, MTU, IBM, Telekom, Infineon, Airbus, SAP, Gerresheimer im ... | Der DAX hat am Montag Verluste einstecken müssen. Aus dem Handel ging er mit einem Minus von 1,1 Prozent bei 24.991,97 Punkten. Der Start in den Dienstag dürfte hingegen etwas freundlicher sein. Der... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,020 | +1,22 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 7,430 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance | ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,130 | -0,58 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,150 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| CLEARPOINT NEURO | 9,805 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen |